LivaNova has filed a patent for a dual lumen coaxial cannula assembly allowing selective axial displacement of an infusion tube through a drainage tube. The connector assembly enables this movement, enhancing medical procedures involving simultaneous infusion and drainage. GlobalData’s report on LivaNova gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on LivaNova, Wearable defibrillators was a key innovation area identified from patents. LivaNova's grant share as of January 2024 was 66%. Grant share is based on the ratio of number of grants to total number of patents.
Dual lumen coaxial cannula assembly for selective axial displacement
See Also:
A dual lumen coaxial cannula assembly has been patented, comprising a first infusion tube and a second drainage tube co-axially aligned with a connector assembly allowing selective axial displacement of the first infusion tube through the second drainage tube. The connector assembly includes valves to secure the first infusion tube, magnets for position feedback, and infusion and drainage apertures at the distal ends of the tubes. This assembly aims to assist a patient's heart by inserting the cannula into the internal jugular vein, maneuvering it to the pulmonary artery and right atrium, adjusting the axial position, securing the tubes, and connecting to a blood pump for right ventricular support.
The patented method for assisting a patient's heart involves inserting the dual lumen coaxial cannula into the internal jugular vein, maneuvering it to the pulmonary artery and right atrium, adjusting the axial position, securing the tubes with valves, and connecting to a blood pump for right ventricular support. The method includes using magnets for position feedback, delivering blood to the pulmonary artery through infusion apertures, and withdrawing blood from the right atrium through drainage apertures. This innovative assembly and method provide a precise and secure way to support a patient's heart function, ensuring proper positioning and functionality for effective treatment.
To know more about GlobalData’s detailed insights on LivaNova, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
